Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms
NCT00408954
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
UK-369,003
DRUG:
UK-369,003
Sponsor
Pfizer